Bidirectional Transcriptome Analysis of Rat Bone Marrow-Derived Mesenchymal Stem Cells and Activated Microglia in an

Da Yeon Lee1, Moon Suk Jin1, Balachandran Manavalan1

  • 1Department of Physiology and Department of Biomedical Sciences, Ajou University School of Medicine, Suwon, Republic of Korea.

Stem Cells International
|August 29, 2018
PubMed

Insights

Bone marrow-derived mesenchymal stem cells (BM-MSCs) migrate towards activated microglia. These stem cells then reduce the inflammatory response of microglia, offering potential for treating brain diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Stem Cell Biology

Background:

  • Microglia are key regulators of neuroinflammation and implicated in brain disease pathogenesis.
  • Modulating microglial neuroinflammation is a promising therapeutic strategy for neurological disorders.
  • Bone marrow-derived mesenchymal stem cells (BM-MSCs) exhibit anti-inflammatory properties beneficial for brain conditions.

Purpose of the Study:

  • To investigate the gene expression changes in rat BM-MSCs (rBM-MSCs) co-cultured with lipopolysaccharide (LPS)-stimulated microglia.
  • To analyze the functional pathways involved in the interaction between rBM-MSCs and activated microglia.
  • To evaluate the reciprocal effects of rBM-MSCs on LPS-induced microglial inflammatory responses.

Main Methods:

  • Microarray analysis of rBM-MSCs co-cultured with LPS-stimulated primary rat microglia.
  • Ingenuity Pathway Analysis (IPA) for functional relationship prediction.
  • Reverse co-culture system to assess rBM-MSC effects on LPS-stimulated microglia.

Main Results:

  • Co-culture with LPS-stimulated microglia induced differential gene expression in rBM-MSCs, primarily related to cell migration (67 genes).
  • Experimental validation confirmed that LPS-stimulated microglia enhance rBM-MSC migration.
  • rBM-MSCs modulated the transcriptome of LPS-stimulated microglia, altering 65 genes related to inflammatory response, thereby reducing inflammation.

Conclusions:

  • LPS-stimulated microglia promote rBM-MSC migration.
  • rBM-MSCs effectively decrease the inflammatory activity of LPS-stimulated microglia.
  • This study elucidates the complex interaction between activated microglia and rBM-MSCs, supporting stem cell-based therapeutic development for brain diseases.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.6K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.2K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.5K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.1K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K